How do I compare drug manufacturers general stocks?

Compare using valuation ratios (P/E, P/B, EV/EBITDA), profitability metrics, growth rates, and financial health indicators. Direct comparison within the same industry provides meaningful insights.

What to consider when investing in drug manufacturers general stocks?

Consider industry trends, competitive positioning, valuation relative to peers, financial strength, management quality, and dividend sustainability for income-focused investments.

Drug Manufacturers General Stocks - Companies, Performance & Financial Metrics

Q: How many stocks are in the drug manufacturers general industry?

There are 21 publicly traded stocks in the drug manufacturers general industry, part of the Healthcare sector.

Browse 21 drug manufacturers general stocks with financial metrics and performance data (Healthcare sector).

Drug Manufacturers General Stocks

21 stocks in the drug manufacturers general industry. Click column headers to sort.

#
1	LLY	Eli Lilly and Company	$935.58	$840.15B	$65.18B	$20.64B	$22.98	2.69M
2	JNJ	Johnson & Johnson	$243.04	$590.44B	$94.19B	$26.80B	$10.99	6.58M
3	ABBV	AbbVie Inc.	$208.84	$373.97B	$61.16B	$4.23B	$2.38	5.06M
4	AZN	AstraZeneca PLC	$203.49	$317.85B	$58.74B	$10.22B	$6.54	2.05M
5	NVS	Novartis AG	$154.03	$301.13B	$56.67B	$13.98B	$7.25	2.62M
6	MRK	Merck & Co., Inc.	$120.87	$300.72B	$65.01B	$18.25B	$7.34	6.25M
7	AMGN	Amgen Inc.	$347.94	$188.93B	$36.75B	$7.71B	$14.20	1.60M
8	GILD	Gilead Sciences, Inc.	$139.71	$175.34B	$29.44B	$8.51B	$6.79	4.58M
9	NVO	Novo Nordisk A/S	$36.98	$164.48B	$47.63B	$15.79B	$3.55	14.56M
10	PFE	Pfizer Inc.	$28.32	$161.03B	$62.58B	$7.77B	$1.37	28.96M
11	B BMY	Bristol-Myers Squibb Company	$59.60	$121.52B	$48.20B	$7.05B	$3.46	13.49M
12	SNY	Sanofi	$47.89	$116.89B	$53.82B	$9.00B	$3.69	1.51M
13	GSK	GSK plc	$56.69	$116.70B	$42.97B	$7.53B	$3.69	3.86M
14	BIIB	Biogen Inc.	$177.34	$26.09B	$9.89B	$1.29B	$8.81	1.34M
15	AMRN	Amarin Corporation plc	$14.74	$6.12B	$183.87M	-$38.80M	$-0.09	13.17K
16	GRFS	Grifols, S.A.	$8.24	$5.61B	$8.65B	$462.09M	$0.68	758.49K
17	OGN	Organon & Co.	$6.36	$1.66B	$6.22B	$187.00M	$0.72	3.40M
18	SCLX	Scilex Holding Company	$7.44	$86.33M	$40.36M	-$332.08M	$-28.62	54.01K
19	NSRX	Nasus Pharma Ltd.	$2.35	$50.52M	—	-$1.53M	$-0.22	15.83K
20	MIRA	MIRA Pharmaceuticals, Inc.	$1.11	$21.40M	$0.00	-$6.86M	$-0.36	132.86K
21	MDCX	Medicus Pharma Ltd.	$0.45	$8.33M	$0.00	-$29.53M	$-1.59	575.15K

About the Drug Manufacturers General Industry

The Drug Manufacturers General industry comprises 21 publicly traded companies within the Healthcare sector that share similar business models and competitive dynamics.

Company Types

- Industry leaders with market share and scale
- Growth companies expanding rapidly
- Value opportunities below peer averages
- Dividend payers for income investors

Key Considerations

- Compare valuation ratios to industry peers
- Assess competitive positioning and moats
- Monitor regulatory and technology trends
- Evaluate financial health and cash flow